Ibudilast - MN-166
In 2013, MediciNova announced the initiation of a Phase 2b trial of MN-166 (ibudilast) in subjects with progressive multiple sclerosis through an NIH-based grant.
It is also being looked at for treating Progressive Multiple Sclerosis, ALS, and Methamphetamine Addiction.
Here is the article. Looks promising.
http://medicinova.com/clinical-devel...ple-sclerosis/
Here are the clinical trial results:
https://clinicaltrials.gov/ct2/show/...udilast&rank=6
I am keeping an eye on this one and Anti-Lingo 1.
It is also being looked at for treating Progressive Multiple Sclerosis, ALS, and Methamphetamine Addiction.
Here is the article. Looks promising.
http://medicinova.com/clinical-devel...ple-sclerosis/
Here are the clinical trial results:
https://clinicaltrials.gov/ct2/show/...udilast&rank=6
I am keeping an eye on this one and Anti-Lingo 1.